$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > 郭亚兵

贝伐珠单抗|上市信息

医保上新,晚期肝癌柳暗花明
  • 医保上新,晚期肝癌柳暗花明
  • 贝伐珠单抗是一种人源化抗体血管内皮生长因子(VEGF)抑制剂,也就是我们熟知的抗血管生成药,通过阻断VEGF与受体的结合,减少新生血管形成,干扰肿瘤血液供应,从而抑制肿瘤生长和扩散。...|阅读全文
  • 发布日期 2021-12-07 21:20:21